NeoGenomics, Inc. Contract with Customer, Liability, Noncurrent
NeoGenomics, Inc. (NEO) had Contract with Customer, Liability, Noncurrent of $334.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2026-07-28
- 2026-06-30: Contract with Customer, Liability, Noncurrent $334.00K.
- 2026-03-31: Contract with Customer, Liability, Noncurrent $338.00K.
- 2025-12-31: Contract with Customer, Liability, Noncurrent $386.00K.
- 2025-09-30: Contract with Customer, Liability, Noncurrent $507.00K.
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $334.00K 10-Q · filed 2026-07-28 |
| 2026-03-31 | $338.00K 10-Q · filed 2026-04-28 |
| 2025-12-31 | $386.00K 10-Q · filed 2026-07-28 |
| 2025-09-30 | $507.00K 10-Q · filed 2025-10-28 |
| 2025-06-30 | $443.00K 10-Q · filed 2025-07-29 |
| 2025-03-31 | $299.00K 10-Q · filed 2025-04-29 |
| 2024-12-31 | $336.00K 10-K · filed 2026-02-17 |
| 2024-09-30 | $396.00K 10-Q · filed 2024-11-05 |
| 2024-06-30 | $349.00K 10-Q · filed 2024-07-30 |
| 2024-03-31 | $0.00 10-Q · filed 2024-04-30 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-18 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-06 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 |
| 2022-12-31 | $19.00K 10-K · filed 2024-02-20 |
| 2022-09-30 | $1.13M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.12M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.08M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $917.00K 10-K · filed 2023-02-24 |
| 2021-09-30 | $932.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $794.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $705.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $712.00K 10-K · filed 2022-02-25 |
| 2020-09-30 | $657.00K 10-Q · filed 2020-10-29 |
| 2020-06-30 | $631.00K 10-Q · filed 2020-07-31 |
| 2020-03-31 | $526.00K 10-Q · filed 2020-04-29 |
| 2019-12-31 | $1.17M 10-K · filed 2021-02-25 |
| 2019-09-30 | $1.90M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $1.81M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $1.94M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.65M 10-K · filed 2020-02-28 |
| 2018-09-30 | $1.20M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $648.00K 10-Q · filed 2018-08-06 |
| 2018-03-31 | $522.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $283.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |